Wide Ranks

ITRM

Iterum Therapeutics plc

2.03

Top Statistics
Market Cap 55 M Forward PE -2.48 Revenue Growth 0.00 %
Current Ratio 0.82 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -1.09 Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins
Balance Sheet
Total Cash 11 M Total Cash Per Share 0.5160 Total Debt 21 M
Total Debt To Equity Current Ratio 0.82 Book Value Per Share -0.4740
All Measures
Short Ratio 46.00 % Message Board Id finmb_318354064 Shares Short Prior Month 215246
City Dublin Uuid 2a47ad90-f2ae-3045-b6c4-2f53ded8d73b Previous Close 2.05
First Trade Date Epoch Utc 1 B Book Value -0.4740 Beta 2.25
Total Debt 21 M Volume 1 M Last Split Date 1 B
Fifty Two Week Low 0.8080 Total Cash Per Share 0.5160 Shares Short Previous Month Date 1 B
Target Median Price 7.50 Max Age 86400 Recommendation Mean 2.00
Sand P52 Week Change 0.3133 Target Mean Price 7.50 Net Income To Common -28337000
Short Percent Of Float 0.1153 Implied Shares Outstanding 27 M Trailing Peg Ratio None
Last Fiscal Year End 1 B Average Daily Volume10 Day 1 M Average Volume10days 1 M
Total Cash 11 M Next Fiscal Year End 1 B Held Percent Insiders 0.0181
Trailing PE 0.0000 Date Short Interest 1 B Most Recent Quarter 1 B
Regular Market Previous Close 2.05 Target Low Price 5.00 Gmt Off Set Milliseconds -18000000
Fifty Day Average 1.27 Open 2.09 Free Cashflow -28464500
Dividend Yield 0.00 % Return On Assets -0.7335 Time Zone Short Name EST
Trailing Eps -1.76 Day Low 2.02 Address1 Fitzwilliam Court
Shares Outstanding 27 M Price Hint 4 Target High Price 10.00
Website https://www.iterumtx.com 52 Week Change 0.0798 Average Volume 2 M
Forward Eps -0.6600 Recommendation Key buy Compensation As Of Epoch Date 1 B
Quick Ratio 71.00 % Last Split Factor 1:15 Regular Market Day High 2.19
Is_sp_500 False Profit Margins 0.00 % Fifty Two Week High 2.34
Day High 2.19 Shares Short 2 M Regular Market Open 2.09
Industry Key biotechnology Earnings Growth 0.00 % Revenue Growth 0.00 %
Shares Percent Shares Out 0.1115 Operating Cashflow -41950000 Currency USD
Time Zone Full Name America/New_York Market Cap 55 M Is_nasdaq_100 False
Zip D02 YW24 Quote Type EQUITY Industry Biotechnology
Long Name Iterum Therapeutics plc Regular Market Day Low 2.02 Held Percent Institutions 0.0899
Current Price 2.03 Address2 1st Floor Leeson Close Enterprise To Ebitda -1.09
Financial Currency USD Current Ratio 0.82 Industry Disp Biotechnology
Number Of Analyst Opinions 2 Country Ireland Float Shares 21 M
Two Hundred Day Average 1.34 Enterprise Value 40 M Forward PE -2.48
Regular Market Volume 1 M Ebitda -37364000 Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States.

It is developing sulopenem, a novel anti-infective compound with oral and intravenous formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections.

The company was incorporated in 2015 and is headquartered in Dublin, Ireland.